Connect with us

Culture

CBD Cleared For Use By Athletes

Published

on

A top sports regulator just changed its rules to allow athletes to use a component of marijuana without punishment.

Cannabidiol, better known as CBD, has gotten a lot of attention in recent years as a therapeutic compound of the cannabis plant.

Unlike its psychoactive cousin tetrahydrocannabinol, or THC, CBD doesn’t leave consumers with a high. But it has been shown to relieve severe seizure disorders, and there is mounting evidence that it has pain-relieving, neuroprotective and other beneficial properties as well.

The World Anti-Doping Agency (WADA) moved last week to officially allow athletes to begin using CBD without fear of being suspended from competition.

WADA, created by the International Olympic Committee in 1999, maintains a list of approved and banned substances that is used by hundreds of sports organizations around the world.

The organization’s 2018 List of Prohibited Substances and Methods makes a clear exception for the use of CBD:

WADA’s 2017 version of the same document contained no such CBD carve-out:

Whole-plant marijuana and THC are still banned under the new rules, which go into effect on January 1. That’s a crucial point, because “cannabidiol extracted from cannabis plants may also contain varying concentrations of THC,” explains a separate WADA document summarizing changes to the organization’s banned drugs list.

WADA’s new policy on CBD was first reported by MMA Imports.

Photo courtesy of Marijuana Muscle.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Tom Angell is the editor of Marijuana Moment. A 20-year veteran in the cannabis law reform movement, he covers the policy and politics of marijuana. Separately, he founded the nonprofit Marijuana Majority. Previously he reported for Marijuana.com and MassRoots, and handled media relations and campaigns for Law Enforcement Against Prohibition and Students for Sensible Drug Policy. (Organization citations are for identification only and do not constitute an endorsement or partnership.)

Culture

Seth Rogen And Sarah Silverman Partner With Marijuana Businesses To Press Senators For Legalization

Published

on

A coalition of marijuana advocacy and industry groups—as well as celebrities like Seth Rogen and Sarah Silverman—launched a campaign on Tuesday meant to encourage voters to reach out to their senators and demand action on legislation to federally legalize cannabis.

The “Cannabis In Common” campaign is being led by the U.S. Cannabis Council (USCC) and HeadCount’s Cannabis Voter Project. The organizations teamed up with a slew of major marijuana businesses like Canopy Growth, Columbia Care, Cresco Labs and Weedmaps for the initiative.

In a direct-to-camera video that was produced for the campaign, Rogen said that “despite what you may have heard, Americans can actually agree on something—and that something is weed.” He referenced polling that shows strong, majority support for legalization. Recent surveys have found the issue is increasingly bipartisan, too.

“You know who cannot agree on anything though? Politicians,” the comedian, who also owns the cannabis business Houseplant, said, adding that fewer than half of U.S. senators have voiced support for reform and others have remained silent on the topic.

“With the Senate about consider a landmark bill that would legalize cannabis at the federal level and wipe cannabis convictions from thousands of people’s records, their silence could end up being the difference,” Rogen said. “But here’s the thing about elected officials: they actually spend most of their time worrying about getting reelected. So when their inboxes and their phone lines are blowing up with constituents all rallying behind something specific, that is when things actually start to happen.”

Senate Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ) have been working that “landmark” legislation—the Cannabis Administration and Opportunity Act (CAOA)—and released a draft version earlier this year. Advocates are eagerly awaiting the final product.

“Legalizing cannabis for good is long past due, but if we make enough noise, we can make it happen,” Rogen said. He encouraged people to use a new resource to fill out and submit pre-written emails to their representatives, or call their offices, to push for the end of prohibition.

Silverman, meanwhile, narrated an animated video that made a similar call to action and highlighted the popularity of legalization.

“Americans can’t agree on anything, can we? Is it ‘gif’ or ‘jiff’? Are hotdogs sandwiches? Is wrestling a sport?” she said. “Fortunately, there’s at least one thing most Americans have in common: more than two-thirds of us agree cannabis should be legalized, and we have a real shot at getting federal legalization done now if we speak up.”

“If we don’t make a change soon, we’re settling for laws that disproportionately land people of color in prison,” Silverman said. “We’re leaving hundreds of thousands of jobs on the table and giving up tax revenue that can go toward education and other community investments.”

Comedian Jessimae Peluso also participated in the campaign, releasing her own video urging voters to make their voices heard and contact their senators about the pending legalization bill.

“We are thrilled to launch this first-of-its-kind campaign,” Steven Hawkins, CEO of USCC, said in a press release. “We are creating a lasting grassroots engagement platform that will harness the collective power of cannabis consumers and advocates. An overwhelming majority of Americans hold our views. It’s time for Congress to catch up.”

Cannabis businesses that are partnering in the campaign will be taking several steps to encourage their customers to contact their lawmakers about the need for legalization by submitting the pre-written letters, including promoting the call-to-action over social media and email, in-store prompts with QR codes and more.

While advocacy groups like the Marijuana Policy Project and Students for Sensible Drug Policy are listed as partners in the campaign, others like the Drug Policy Alliance (DPA) are weary of aligning with a largely industry-backed initiative.

“For us, it’s not just about getting federal legalization over the finish line,” DPA’s Maritza Perez told The Associated Press. “We have a very specific constituency that we are fighting for, and that’s people who have been impacted by prohibition.”

Beside the Senate bill, the House Judiciary Committee also recently passed a separate legalization bill, the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act. It cleared the full House last session but was not taken up by the GOP-controlled Senate.

Additionally, a new Republican-led effort to federally legalize and tax cannabis will soon be introduced in the House.

Biden Administration Will Keep Denying Public Housing Over Marijuana Despite Congresswoman’s Request

Photo courtesy of Mike Latimer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Culture

Singer Melissa Etheridge And Activist Van Jones Promote Psychedelics Reform As Movement Grows

Published

on

The fight to end the criminalization of psychedelics and give patients access to natural plants and fungi has achieved success in a growing number of cities and states in recent years, and on Thursday the cause got a boost from prominent people in the entertainment and political fields.

Musician Melissa Etheridge and criminal justice reform activist Van Jones spoke at an event hosted by the nonprofit group End Well, which focused on how certain psychedelics can help ease in end-of-life anxiety and other mental health conditions. Both Etheridge and Jones spoke about the need to break with the status quo and allow patients to access alternative treatments.

Etheridge has become an outspoken advocate for marijuana reform in the years since she started using the plant medicinally after being diagnosed with breast cancer in her 40s.

She said at the virtual event that she feels the “discussion of psychedelics and plant medicine is extremely important,” and she has “a deep belief that these entheogens—these plant medicines that have been available on Earth since the beginning of time—play a big part and are here for the purpose of helping us humans guide ourselves and our loved ones.”

“I truly believe that psilocybin is a real key to helping people through the fear of death,” she said in her opening remarks for the End in Mind conference.

Asked by Marijuana Moment about whether she plans to use her influence to similarly advance psychedelics reform as she has with cannabis, Etheridge said she’s “feeling very positive about all the state and local psychedelic reforms that are coming.”

“I’m definitely going to do what I can to be an advocate for this and maybe help people understand how these plant medicines can play a very important role in our human life and experience,” she said.

Jones, meanwhile, stressed that he’s not somebody with personal experience using intoxicating substances—even legal products like wine. But he sees the value in ending criminalization, and psychedelics reform is part of the solution.

“When you’re trying to solve real problems, you very quickly realize you need big coalitions. Connection is key to that,” he said. “I’m not someone with personal experience, but people who I trust and respect have reported to me that some of the most powerful, expansive experiences that they’ve had have been supported by some of these substances.”

Jones might not have a personal history of using psychedelics despite participating in Thursday’s event, but as he listed off the various drugs he hasn’t tried, he did include a notable caveat in his discussion.

“I am as fair and reasonable a person on this as you possibly can,” he said. “I’ve never—I have not yet—tried ayahuasca, mushrooms, nothing. I am as straight as you can get on this stuff.” The operative term there is “yet,” though Jones didn’t go any further in suggesting he might be open to experimenting with psychedelics at some point.

The criminal justice reform activists also addressed the need for broader drug policy reform beyond psychedelics.

“What I’m saying is that, for some of the intoxicants that have caused a lot of harm, we need a better approach than locking people up for those,” he said. “And for those that are more medicinal and that have medicinal uses, we need better access to those.”

Activists across the U.S. are working to advance these reforms. Cities across the U.S. have already enacted policies to deprioritize enforcement of laws against certain psychedelics like psilocybin and ayahuasca.

Last week, advocates helped to effectively decriminalize a wide range of psychedelics, with the Arcata City Council unanimously approving the reform. That marked the third California city to decriminalize psychedelics, following similar reforms that lawmakers have enacted in Oakland and Santa Cruz.

In Oakland, the first city in the country where a city council voted to broadly deprioritize criminalization of entheogenic substances, lawmakers approved a follow-up resolution in December that calls for the policy change to be adopted statewide and for local jurisdictions to be allowed to permit healing ceremonies where people could use psychedelics.

A bill to legalize psychedelics in California advanced through the Senate and two Assembly committees this year before being pulled by the sponsor to buy more time to generate support among lawmakers. The plan is to take up the reform during next year’s second half of the legislative session, and the senator behind the measure says he’s confident it will pass.

California activists are separately collecting signatures for a ballot initiative to legalize psilocybin mushrooms in the state.

Seattle’s City Council recently approved a resolution to decriminalize noncommercial activity around a wide range of psychedelic substances, including the cultivation and sharing of psilocybin mushrooms, ayahuasca, ibogaine and non-peyote-derived mescaline.

Detroit could be one of the next to enact a policy change, with voters set to weigh in on a local ballot measure next month to decriminalize entheogenic substances.

At the same time that local advocates are pursuing reform, a pair of Michigan state senators introduced a bill last month to legalize the possession, cultivation and delivery of an array of plant- and fungus-derived psychedelics like psilocybin and mescaline. If voters in the state’s most populous city approve the local measure, it could make state lawmakers take a more serious look at broader reform.

Also in Michigan, the Grand Rapids City Council approved a resolution last month calling for decriminalization of a wide range of psychedelics. The Ann Arbor City Council has already elected to make enforcement of laws prohibition psychedelics like psilocybin, ayahuasca and DMT among the city’s lowest priorities—and lawmakers recently followed up by declaring September Entheogenic Plants and Fungi Awareness Month.

After Ann Arbor legislators passed that decriminalization resolution last year, the Washtenaw County prosecutor announced that his office will not be pursuing charges over possessing entheogenic plants and fungi, “regardless of the amount at issue.”


Marijuana Moment is already tracking more than 1,200 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

The top Democrat in the Florida Senate filed a bill last month that would require the state to research the medical benefits of psychedelics such as psilocybin and MDMA.

Earlier this year, Texas enacted a law directing state officials to study psychedelics’ medical value.

The governor of Connecticut signed a bill in June that includes language requiring the state to carry out a study into the therapeutic potential of psilocybin mushrooms.

Oregon voters passed a pair of initiatives last November to legalize psilocybin therapy and decriminalize possession of all drugs. On the local level, activists in Portland are mounting a push to have local lawmakers pass a resolution decriminalizing the cultivation, gifting and ceremonial use of a wide range of psychedelics.

Washington, D.C. voters also approved a ballot measure last year to deprioritize enforcement of laws criminalizing psychedelics.

In Massachusetts, the Northampton City Council passed a resolution in April stipulating that no government or police funds should be used to enforce laws criminalizing people for using or possessing entheogenic plants and fungi. Somerville and Cambridge have also moved to effectively decriminalize psychedelics.

A New York lawmaker introduced a bill in June that would require the state to establish an institute to similarly research the medical value of psychedelics.

The Maine House of Representatives passed a drug decriminalization bill this year, but it later died in the Senate.

Meanwhile, Denver activists who successfully led the 2019 campaign to make the city the first in the U.S. to decriminalize psilocybin possession have set their eyes on broader reform, with plans in the works to end the criminalization of noncommercial gifting and communal use of the psychedelic. A city panel there is recommending expansion of the decriminalization policy to cover gifting and social use.

In a setback for advocates, the U.S. House of Representatives recently voted against a proposal from Rep. Alexandria Ocasio-Cortez (D-NY) that would have removed a spending bill rider that advocates say has restricted federal funds for research into Schedule I drugs, including psychedelics such as psilocybin, MDMA and ibogaine. However, it picked up considerably more votes this round than when the congresswoman first introduced it in 2019.

Report provisions of separate, House-passed spending legislation also touch on the need to expand cannabis and psychedelics research. The panel urged NIDA to support expanded marijuana studies, for example. It further says that federal health agencies should pursue research into the therapeutic potential of psychedelics for military veterans suffering from a host of mental health conditions.

There was an attempt by a Republican congressman to attach language into a defense spending bill that would promote research into psychedelics therapy for active duty military members, but it was not made in order in the House Rules Committee last month.

For what it’s worth, Rep. Earl Blumenauer (D-OR), a longstanding champion of marijuana reform in Congress, said this month that he intends to help bring the psychedelics reform movement to Capitol Hill “this year.”

Report provisions of separate, House-passed spending legislation also touch on the need to expand cannabis and psychedelics research. The panel urged NIDA to support expanded marijuana studies, for example. It further says that federal health agencies should pursue research into the therapeutic potential of psychedelics for military veterans suffering from a host of mental health conditions.

NIDA also recently announced it’s funding a study into whether psilocybin can help people quit smoking cigarettes.

An official with the U.S. Department of Veterans Affairs also said at a recent congressional hearing that the agency is “very closely” following research into the potential therapeutic benefits of psychedelics like MDMA for military veterans.

In May, lawmakers in Congress filed the first-ever legislation to federally decriminalize possession of illicit substances.

Florida Democratic Candidates For Governor Fight Over Who Supports Marijuana Reform The Most

Photo elements courtesy of carlosemmaskype and Apollo.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Culture

Sanjay Gupta Explains His Marijuana Reversal And Discusses ‘Very Biased’ U.S. Research With Joe Rogan

Published

on

CNN’s chief medical correspondent Sanjay Gupta wasn’t always on board with medical marijuana, but things changed when he looked for the science, he said during an interview on the Joe Rogan Experience on Wednesday.

But to find the science that ultimately convinced him of the therapeutic potential of cannabis, he had to look internationally, because there seemed to be a “very biased set of data” in the U.S. that focused almost exclusively on the potential harms rather than benefits.

“If you’re just looking at papers—well, this one [says there’s] potential long harm, this one possible addiction, this one gateway—you know, you’re seeing all those individual studies, but at a broader level, one step upstream, you realize that most of the studies that are getting funded are designed to look for harm,” Gupta said.

“When I saw that, that was the first time I thought, ‘well, why are the studies that are getting out there, why are they all designed to look for harm?” he said. “Then I started looking at other countries, and some really good research out of places like Israel in particular.”

Scientists outside of the U.S. were taking a different approach, investigating potential therapeutic applications for marijuana for conditions like pain and seizures. That—combined with witnessing the measurable impact of cannabinoids for children with severe epilepsy—changed Gupta’s mind on the issue. And he took a bold step in 2013 of penning an article for CNN explaining why his perspective had shifted form being a cannabis skeptic to a supporter.

This was at a time when the first states were beginning to legalize marijuana for adult use, forcing people to consider the implications of ending prohibition and giving adults access to the plant. Reading an article from a high-profile practicing physician that challenged the narrative of cannabis being all bad may well have done much to change hearts and minds at a pivotal time.

Prior to writing that op-ed, Gupta also hosted a CNN docu-series called “Weed” that also explored the science and real-world experiences of people who’ve seen dramatic health benefits from the use of cannabis.

Rogan told Gupta that he “really respected that you made this change of opinion publicly.”

“When you were first talking about marijuana, you were talking about it as if it had no medical benefit and it was really just a recreational drug that was possibly or probably harmful,” the podcaster said. “But then, upon further examination, you publicly changed your position, and, in doing so, you actually examined all the scientific evidence.”

“I really admired that because that takes a lot of courage, because a lot of people, when they have an idea and they proclaim it publicly, they double down and they just [use] confirmation bias and whatever, you know, echo chamber and news sources they can get to sort of confirm their initial position,” he said. “You didn’t do that, and I thought, ‘that’s a real, real thinking person who is trying to honestly figure out what’s going on instead of just working on being right.'”

Rogan is well known as an advocate for drug policy reform, and he often takes opportunities to discuss issues like marijuana and psychedelics with guests on his podcast.

Tech entrepreneur Elon Musk got himself into hot water after smoking a blunt with Rogan in 2018, and he made another appearance on the show this year where he argued that there’s excess hype over CBD, only to be challenged with the science by the host.

In 2019, Rogan reminisced about a time he attended a film premiere with comedian Dave Chappelle, who he said took magic mushrooms from a stranger prior to the feature.

That year, former boxer Mike Tyson spoke with the podcast host about tripping on psychedelics and smoking marijuana.

In 2019, Sen. Bernie Sanders (I-VT) talked to Rogan about his support for marijuana legalization.

Rep. Tulsi Gabbard (D-HI) went on the podcast the prior year and spoke at length about the need to legalize marijuana and reform the criminal justice system. Rogan also took the opportunity to tell her a bit about about the medical benefits of psychedelics.

The podcaster also debated the merits of marijuana legalization with a Republican congressman, Rep. Dan Crenshaw (D-TX), who ultimately conceded that medical cannabis should be federally legal and states should be empowered to set their own legalization policies.

Nevada Sold More Than $1 Billion In Marijuana In One Year, Officials Report

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Marijuana Moment